FOOD-INDUCED REDUCTION IN BIOAVAILABILITY OF ATENOLOL

被引:55
作者
MELANDER, A
STENBERG, P
LIEDHOLM, H
SCHERSTEN, B
WAHLINBOLL, E
机构
[1] UNIV LUND HOSP,DEPT MED,S-22185 LUND,SWEDEN
[2] MALMO GEN HOSP PHARM,MALMO,SWEDEN
[3] DEPT COMMUNITY CARE SCI,DALBY,SWEDEN
关键词
atenolol; food intake; pharmacokinetics;
D O I
10.1007/BF00605630
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The influence of food intake on the bioavailability of the beta-adrenoceptor blocker atenolol was assessed by measurement of its single-dose kinetics in ten healthy volunteers, who took 100 mg both in the fasting state and together with a standardized breakfast. Food intake significantly shortened the time to reach peak concentration (2.7 h vs 1.5 h), but caused a significant reduction in AUC values, the mean decrease being 20%. The elimination half-life was unaffected. Atenolol, which is relatively hydrophilic, is incompletely absorbed in the fasting state, and escapes first-pass metabolism. The present findings indicate that food intake causes further impairment of its absorption, even though the absorption rate may initially be enhanced. This contrasts with previous observations on the more lipophilic beta-adrenoceptor blockers propranolol and metoprolol. © 1979 Springer-Verlag.
引用
收藏
页码:327 / 330
页数:4
相关论文
共 16 条
[1]  
ACOCELLA G, 1978, CLIN PHARMACOKINET, V3, P128
[2]  
BATES TR, 1974, CLIN PHARMACOL THER, V16, P63
[3]  
BEERMANN B, EUR J CLIN PHARMACOL
[4]  
COTHAM RH, 1975, CLIN PHARMACOL THER, V18, P535
[5]  
HORNKVIST PE, COMMUNICATION
[6]  
JOHNSSON G, 1976, Clinical Pharmacokinetics, V1, P233
[7]  
LEVY RH, 1975, CLIN PHARMACOL THER, V17, P657
[8]  
MALMBORG AS, 1978, CURR MED RES OPIN, V5, P15
[9]  
MCLEAN AJ, 1978, CLIN PHARMACOL THER, V24, P5
[10]  
MELANDER A, 1977, CLIN PHARMACOL THER, V22, P100